Here's How Sanofi Hopes to Avoid the Patent Cliff [The Motley Fool]
BIOVERATIV INC COMMON (BIVV)
Last bioverativ inc common earnings: 2/13 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bioverativ.com/phoenix.zhtml?c=254463&p=irol-irhome_pf
Company Research
Source: The Motley Fool
Acquisitions may help the company navigate risks. This week, Sanofi ( NYSE:SNY ) announced that it's buying hemophilia drug developer Bioverativ ( NASDAQ:BIVV ) for $11.6 billion. The price tag raised eyebrows because it values Bioverativ at a lofty 10 times trailing-12-month revenue. Why is Sanofi willing to spend so much money to get its hands on this biotech? In this clip from the Motley Fool's Industry Focus: Healthcare , analyst Kristine Harjes is joined by healthcare investor Todd Campbell to discuss how patent expiration may have factored into Sanofi's decision and why Bioverativ's hemophilia products are so intriguing to it. A full transcript follows the video. This video was recorded on Jan. 24, 2018. Kristine Harjes: On Monday, not only did we get confirmation about that Celgene -Juno deal, but Sanofi also announced an all-cash deal to buy Bioverativ for $11.6 billion, or $105 per share. Todd Campbell: Yeah. That
Show less
Read more
Impact Snapshot
Event Time:
BIVV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIVV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIVV alerts
High impacting BIOVERATIV INC COMMON news events
Weekly update
A roundup of the hottest topics